Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 5164.16 | nM | 19273668 | |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | 10914.4 | nM | 9207945 | |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | 5754.4 | nM | 18247546 | |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | 2624.22 | nM | 17958396 | |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | 2523.48 | nM | PubChem BioAssay data set | |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | 3614.1 | nM | 17958396 | |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | 2978.52 | nM | 19015352 | |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | 11402.5 | nM | Open TG-GATES in vivo data: Hematology | |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 4.69 | ug/ml | Open TG-GATES in vivo data: Biochemistry |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | 4395.42 | nM | 24224794 | |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | 2654.61 | nM | PubChem BioAssay data set | |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 5714.79 | nM | 10.6019/CHEMBL3301361 | |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 3741.11 | nM | 21123165 | |
NPT175 | Organism | Enterococcus faecalis | Enterococcus faecalis | MIC | = | 1.17 | ug/ml | 10.6019/CHEMBL1201861 |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | 4130.48 | nM | 10.6019/CHEMBL1201861 | |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 3303.7 | nM | 25479041 | |
NPT79 | Organism | Bacillus subtilis | Bacillus subtilis | MIC | = | 2.34 | ug/ml | 17850214 |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 3881.5 | nM | 10.6019/CHEMBL1201861 | |
NPT83 | Cell Line | MCF7 | Homo sapiens | IC50 | = | 4 | ug/ml | 10.6019/CHEMBL1201861 |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | 3365.12 | nM | 19733087 | |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | 3198.9 | nM | 19604701 | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | 1887.99 | nM | 18160520 | |
NPT575 | Cell Line | KM-20L2 | Homo sapiens | GI50 | 6011.74 | nM | 18936192 | |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | 4187.94 | nM | DrugMatrix in vitro pharmacology data | |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 3741.11 | nM | DrugMatrix in vivo data: Pathology | |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | 6714.29 | nM | 15646539 | |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | 11912.42 | nM | 21458279 | |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | 2426.61 | nM | 15217268 | |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | 7079.46 | nM | 19813743 | |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 7533.56 | nM | 10.1584/jpestics.27.127 | |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 5470.16 | nM | 10.6019/CHEMBL1201861 | |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | 6081.35 | nM | 9514009 | |
NPT574 | Cell Line | XF498 | Homo sapiens | GI50 | 3732.5 | nM | 20055495 | |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | 3863.67 | nM | PubChem BioAssay data set | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 4720.63 | nM | 7131486 | |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | 4355.12 | nM | DrugMatrix in vivo data: Pathology | |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 2735.27 | nM | 10.1039/C3MD00166K | |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | 4864.07 | nM | 25136754 | |
NPT579 | Cell Line | DLD-1 | Homo sapiens | GI50 | 4375.22 | nM | 25211032 | |
NPT572 | Cell Line | DMS-273 | Homo sapiens | GI50 | 5105.05 | nM | 20430633 | |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | 11776.06 | nM | 20151678 | |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | 4446.31 | nM | 19914074 | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | 2606.15 | nM | 20638854 | |
NPT41 | Individual Protein | Aldose reductase | Homo sapiens | Ki | = | 1500 | nM | 24900794 |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 5333.35 | nM | 25725608 | |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | 2404.36 | nM | 23398362 | |
NPT573 | Cell Line | M19-MEL | Homo sapiens | GI50 | 3647.54 | nM | 24973030 | |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | 6606.93 | nM | 12828470 | |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | 4187.94 | nM | 20815366 | |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | 4315.19 | nM | 25978960 | |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | 9862.79 | nM | 25397992 | |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | 2197.86 | nM | 25397992 | |
NPT576 | Cell Line | DMS-114 | Homo sapiens | GI50 | 3076.1 | nM | 20231393 | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | 9225.71 | nM | 20713679 | |
NPT165 | Cell Line | HeLa | Homo sapiens | IC50 | > | 5 | ug/ml | 23350733 |
NPT731 | Cell Line | LXFL 529 | Homo sapiens | GI50 | 3962.78 | nM | 25647077 | |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 3523.71 | nM | 12747798 | |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | 5046.61 | nM | 17850214 | |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | 4456.56 | nM | 22037378 | |
NPT578 | Cell Line | SNB-78 | Homo sapiens | GI50 | 25292.98 | nM | 23107479 | |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | 5321.08 | nM | DrugMatrix in vitro pharmacology data | |
NPT91 | Cell Line | KB | Homo sapiens | IC50 | > | 5 | ug/ml | 22552195 |
NPT139 | Cell Line | HT-29 | Homo sapiens | IC50 | = | 3 | ug/ml | 22824205 |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | 2426.61 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC141574 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9281 | High Similarity | NPC70320 |
0.9221 | High Similarity | NPC3744 |
0.9221 | High Similarity | NPC137125 |
0.9156 | High Similarity | NPC75377 |
0.9139 | High Similarity | NPC68441 |
0.8831 | High Similarity | NPC39361 |
0.8704 | High Similarity | NPC131905 |
0.8701 | High Similarity | NPC300603 |
0.8701 | High Similarity | NPC91694 |
0.869 | High Similarity | NPC216307 |
0.8688 | High Similarity | NPC279605 |
0.8671 | High Similarity | NPC302783 |
0.8671 | High Similarity | NPC473201 |
0.8659 | High Similarity | NPC26386 |
0.8634 | High Similarity | NPC143328 |
0.8581 | High Similarity | NPC275278 |
0.8553 | High Similarity | NPC141368 |
0.8519 | High Similarity | NPC37543 |
0.8519 | High Similarity | NPC167098 |
0.8519 | High Similarity | NPC296044 |
0.8519 | High Similarity | NPC199463 |
0.8512 | High Similarity | NPC4200 |
0.85 | High Similarity | NPC164912 |
0.8491 | Intermediate Similarity | NPC31132 |
0.8488 | Intermediate Similarity | NPC476203 |
0.8488 | Intermediate Similarity | NPC150977 |
0.8476 | Intermediate Similarity | NPC216916 |
0.8476 | Intermediate Similarity | NPC318081 |
0.8457 | Intermediate Similarity | NPC213401 |
0.8457 | Intermediate Similarity | NPC14561 |
0.8457 | Intermediate Similarity | NPC77807 |
0.8457 | Intermediate Similarity | NPC5379 |
0.8452 | Intermediate Similarity | NPC11314 |
0.8447 | Intermediate Similarity | NPC62051 |
0.8438 | Intermediate Similarity | NPC118427 |
0.8438 | Intermediate Similarity | NPC144283 |
0.8438 | Intermediate Similarity | NPC124842 |
0.8424 | Intermediate Similarity | NPC144843 |
0.8424 | Intermediate Similarity | NPC149389 |
0.8418 | Intermediate Similarity | NPC470757 |
0.8415 | Intermediate Similarity | NPC84571 |
0.8415 | Intermediate Similarity | NPC472052 |
0.8415 | Intermediate Similarity | NPC470342 |
0.8415 | Intermediate Similarity | NPC472060 |
0.8405 | Intermediate Similarity | NPC178976 |
0.8397 | Intermediate Similarity | NPC50954 |
0.8393 | Intermediate Similarity | NPC188079 |
0.8393 | Intermediate Similarity | NPC300307 |
0.8385 | Intermediate Similarity | NPC180388 |
0.8373 | Intermediate Similarity | NPC477689 |
0.8373 | Intermediate Similarity | NPC45943 |
0.8373 | Intermediate Similarity | NPC270837 |
0.8373 | Intermediate Similarity | NPC236132 |
0.8373 | Intermediate Similarity | NPC101769 |
0.8364 | Intermediate Similarity | NPC87431 |
0.8364 | Intermediate Similarity | NPC472261 |
0.8364 | Intermediate Similarity | NPC311740 |
0.8354 | Intermediate Similarity | NPC315157 |
0.8354 | Intermediate Similarity | NPC58752 |
0.8354 | Intermediate Similarity | NPC324736 |
0.8344 | Intermediate Similarity | NPC474167 |
0.8344 | Intermediate Similarity | NPC196941 |
0.8344 | Intermediate Similarity | NPC470762 |
0.8344 | Intermediate Similarity | NPC309169 |
0.8333 | Intermediate Similarity | NPC107109 |
0.8333 | Intermediate Similarity | NPC472058 |
0.8333 | Intermediate Similarity | NPC105414 |
0.8333 | Intermediate Similarity | NPC474024 |
0.8333 | Intermediate Similarity | NPC218226 |
0.8333 | Intermediate Similarity | NPC93552 |
0.8333 | Intermediate Similarity | NPC234497 |
0.8333 | Intermediate Similarity | NPC324522 |
0.8333 | Intermediate Similarity | NPC470341 |
0.8323 | Intermediate Similarity | NPC472838 |
0.8323 | Intermediate Similarity | NPC25361 |
0.8323 | Intermediate Similarity | NPC306011 |
0.8313 | Intermediate Similarity | NPC261322 |
0.8313 | Intermediate Similarity | NPC294965 |
0.8313 | Intermediate Similarity | NPC473445 |
0.8313 | Intermediate Similarity | NPC303989 |
0.8313 | Intermediate Similarity | NPC201800 |
0.8304 | Intermediate Similarity | NPC477991 |
0.8304 | Intermediate Similarity | NPC477992 |
0.8303 | Intermediate Similarity | NPC155302 |
0.8303 | Intermediate Similarity | NPC185617 |
0.8303 | Intermediate Similarity | NPC161947 |
0.8303 | Intermediate Similarity | NPC47623 |
0.8302 | Intermediate Similarity | NPC52692 |
0.8293 | Intermediate Similarity | NPC302258 |
0.8291 | Intermediate Similarity | NPC73416 |
0.8291 | Intermediate Similarity | NPC160777 |
0.8284 | Intermediate Similarity | NPC475212 |
0.8284 | Intermediate Similarity | NPC117911 |
0.8284 | Intermediate Similarity | NPC476279 |
0.8282 | Intermediate Similarity | NPC66508 |
0.8282 | Intermediate Similarity | NPC226656 |
0.8274 | Intermediate Similarity | NPC43065 |
0.8274 | Intermediate Similarity | NPC224851 |
0.8274 | Intermediate Similarity | NPC43319 |
0.8274 | Intermediate Similarity | NPC320741 |
0.8274 | Intermediate Similarity | NPC171985 |
0.8272 | Intermediate Similarity | NPC131121 |
0.8266 | Intermediate Similarity | NPC324742 |
0.8266 | Intermediate Similarity | NPC185275 |
0.8266 | Intermediate Similarity | NPC120102 |
0.8263 | Intermediate Similarity | NPC7483 |
0.8263 | Intermediate Similarity | NPC291977 |
0.8263 | Intermediate Similarity | NPC197168 |
0.8256 | Intermediate Similarity | NPC478050 |
0.8253 | Intermediate Similarity | NPC189552 |
0.8253 | Intermediate Similarity | NPC278052 |
0.8253 | Intermediate Similarity | NPC475883 |
0.8253 | Intermediate Similarity | NPC474351 |
0.8253 | Intermediate Similarity | NPC469889 |
0.8253 | Intermediate Similarity | NPC273467 |
0.8253 | Intermediate Similarity | NPC66288 |
0.8253 | Intermediate Similarity | NPC40491 |
0.8246 | Intermediate Similarity | NPC199357 |
0.8242 | Intermediate Similarity | NPC85121 |
0.8242 | Intermediate Similarity | NPC45846 |
0.8239 | Intermediate Similarity | NPC269625 |
0.8235 | Intermediate Similarity | NPC472803 |
0.8235 | Intermediate Similarity | NPC180768 |
0.8235 | Intermediate Similarity | NPC131866 |
0.8232 | Intermediate Similarity | NPC478223 |
0.8221 | Intermediate Similarity | NPC475770 |
0.8221 | Intermediate Similarity | NPC273248 |
0.8221 | Intermediate Similarity | NPC474000 |
0.8217 | Intermediate Similarity | NPC141817 |
0.8217 | Intermediate Similarity | NPC176030 |
0.8217 | Intermediate Similarity | NPC192597 |
0.8217 | Intermediate Similarity | NPC169214 |
0.8217 | Intermediate Similarity | NPC229218 |
0.8214 | Intermediate Similarity | NPC475888 |
0.8214 | Intermediate Similarity | NPC303174 |
0.8214 | Intermediate Similarity | NPC469664 |
0.8214 | Intermediate Similarity | NPC293319 |
0.8214 | Intermediate Similarity | NPC477840 |
0.821 | Intermediate Similarity | NPC35 |
0.821 | Intermediate Similarity | NPC78505 |
0.8208 | Intermediate Similarity | NPC265380 |
0.8205 | Intermediate Similarity | NPC82336 |
0.8205 | Intermediate Similarity | NPC78987 |
0.8204 | Intermediate Similarity | NPC474162 |
0.8204 | Intermediate Similarity | NPC116838 |
0.8204 | Intermediate Similarity | NPC42797 |
0.8204 | Intermediate Similarity | NPC474150 |
0.8204 | Intermediate Similarity | NPC22130 |
0.8204 | Intermediate Similarity | NPC15374 |
0.8198 | Intermediate Similarity | NPC227906 |
0.8198 | Intermediate Similarity | NPC139350 |
0.8198 | Intermediate Similarity | NPC99591 |
0.8194 | Intermediate Similarity | NPC206207 |
0.8193 | Intermediate Similarity | NPC36217 |
0.8193 | Intermediate Similarity | NPC475886 |
0.8193 | Intermediate Similarity | NPC228785 |
0.8193 | Intermediate Similarity | NPC320359 |
0.8193 | Intermediate Similarity | NPC119224 |
0.8193 | Intermediate Similarity | NPC312993 |
0.8193 | Intermediate Similarity | NPC186325 |
0.8193 | Intermediate Similarity | NPC474287 |
0.8193 | Intermediate Similarity | NPC56085 |
0.8193 | Intermediate Similarity | NPC14353 |
0.8193 | Intermediate Similarity | NPC476506 |
0.8193 | Intermediate Similarity | NPC299436 |
0.8192 | Intermediate Similarity | NPC205721 |
0.8187 | Intermediate Similarity | NPC158226 |
0.8187 | Intermediate Similarity | NPC186847 |
0.8187 | Intermediate Similarity | NPC257667 |
0.8187 | Intermediate Similarity | NPC472454 |
0.8187 | Intermediate Similarity | NPC174700 |
0.8182 | Intermediate Similarity | NPC78103 |
0.8176 | Intermediate Similarity | NPC216403 |
0.8176 | Intermediate Similarity | NPC202428 |
0.8176 | Intermediate Similarity | NPC186100 |
0.8176 | Intermediate Similarity | NPC266545 |
0.8176 | Intermediate Similarity | NPC41494 |
0.8176 | Intermediate Similarity | NPC107627 |
0.8171 | Intermediate Similarity | NPC300757 |
0.8171 | Intermediate Similarity | NPC134287 |
0.8171 | Intermediate Similarity | NPC180901 |
0.8171 | Intermediate Similarity | NPC130589 |
0.8171 | Intermediate Similarity | NPC68727 |
0.8166 | Intermediate Similarity | NPC263212 |
0.8166 | Intermediate Similarity | NPC39091 |
0.8166 | Intermediate Similarity | NPC174734 |
0.8166 | Intermediate Similarity | NPC474042 |
0.8166 | Intermediate Similarity | NPC37870 |
0.8166 | Intermediate Similarity | NPC272560 |
0.8165 | Intermediate Similarity | NPC239608 |
0.8165 | Intermediate Similarity | NPC46161 |
0.8161 | Intermediate Similarity | NPC212290 |
0.8161 | Intermediate Similarity | NPC113446 |
0.816 | Intermediate Similarity | NPC295646 |
0.816 | Intermediate Similarity | NPC470338 |
0.816 | Intermediate Similarity | NPC51824 |
0.816 | Intermediate Similarity | NPC149889 |
0.816 | Intermediate Similarity | NPC113608 |
0.816 | Intermediate Similarity | NPC268992 |
0.816 | Intermediate Similarity | NPC312338 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC141574 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9139 | High Similarity | NPD7422 | Clinical (unspecified phase) |
0.8655 | High Similarity | NPD8397 | Clinical (unspecified phase) |
0.8606 | High Similarity | NPD7473 | Discontinued |
0.8537 | High Similarity | NPD6232 | Discontinued |
0.8144 | Intermediate Similarity | NPD6959 | Discontinued |
0.8046 | Intermediate Similarity | NPD8312 | Approved |
0.8046 | Intermediate Similarity | NPD8313 | Approved |
0.7895 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.7895 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.7895 | Intermediate Similarity | NPD6166 | Phase 2 |
0.7892 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.7861 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7831 | Intermediate Similarity | NPD1934 | Approved |
0.7798 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7798 | Intermediate Similarity | NPD7768 | Phase 2 |
0.7785 | Intermediate Similarity | NPD5406 | Approved |
0.7785 | Intermediate Similarity | NPD5404 | Approved |
0.7785 | Intermediate Similarity | NPD5408 | Approved |
0.7785 | Intermediate Similarity | NPD5405 | Approved |
0.7784 | Intermediate Similarity | NPD2801 | Approved |
0.7778 | Intermediate Similarity | NPD7390 | Discontinued |
0.7738 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.7706 | Intermediate Similarity | NPD6234 | Discontinued |
0.7702 | Intermediate Similarity | NPD7003 | Approved |
0.7651 | Intermediate Similarity | NPD3226 | Approved |
0.7637 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.7627 | Intermediate Similarity | NPD6559 | Discontinued |
0.7622 | Intermediate Similarity | NPD2533 | Approved |
0.7622 | Intermediate Similarity | NPD2534 | Approved |
0.7622 | Intermediate Similarity | NPD2532 | Approved |
0.7619 | Intermediate Similarity | NPD37 | Approved |
0.7614 | Intermediate Similarity | NPD7074 | Phase 3 |
0.7605 | Intermediate Similarity | NPD4380 | Phase 2 |
0.76 | Intermediate Similarity | NPD7228 | Approved |
0.7588 | Intermediate Similarity | NPD3882 | Suspended |
0.7574 | Intermediate Similarity | NPD1465 | Phase 2 |
0.7574 | Intermediate Similarity | NPD7819 | Suspended |
0.7571 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.7558 | Intermediate Similarity | NPD5494 | Approved |
0.7557 | Intermediate Similarity | NPD7054 | Approved |
0.7556 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.7516 | Intermediate Similarity | NPD2346 | Discontinued |
0.7514 | Intermediate Similarity | NPD7472 | Approved |
0.75 | Intermediate Similarity | NPD3818 | Discontinued |
0.7486 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.7485 | Intermediate Similarity | NPD4965 | Approved |
0.7485 | Intermediate Similarity | NPD4966 | Approved |
0.7485 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7455 | Intermediate Similarity | NPD1511 | Approved |
0.7453 | Intermediate Similarity | NPD2935 | Discontinued |
0.744 | Intermediate Similarity | NPD7458 | Discontinued |
0.7427 | Intermediate Similarity | NPD3817 | Phase 2 |
0.7418 | Intermediate Similarity | NPD8150 | Discontinued |
0.7414 | Intermediate Similarity | NPD8127 | Discontinued |
0.741 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.7409 | Intermediate Similarity | NPD8151 | Discontinued |
0.7389 | Intermediate Similarity | NPD7808 | Phase 3 |
0.7378 | Intermediate Similarity | NPD8166 | Discontinued |
0.7372 | Intermediate Similarity | NPD9494 | Approved |
0.7368 | Intermediate Similarity | NPD8455 | Phase 2 |
0.7365 | Intermediate Similarity | NPD1512 | Approved |
0.7341 | Intermediate Similarity | NPD7075 | Discontinued |
0.7337 | Intermediate Similarity | NPD5808 | Clinical (unspecified phase) |
0.7333 | Intermediate Similarity | NPD7251 | Discontinued |
0.7317 | Intermediate Similarity | NPD6674 | Discontinued |
0.7305 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.7293 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.7284 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.7278 | Intermediate Similarity | NPD6797 | Phase 2 |
0.7263 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.7256 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.7251 | Intermediate Similarity | NPD7411 | Suspended |
0.7246 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7244 | Intermediate Similarity | NPD1470 | Approved |
0.7238 | Intermediate Similarity | NPD7685 | Pre-registration |
0.7212 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7208 | Intermediate Similarity | NPD1201 | Approved |
0.7207 | Intermediate Similarity | NPD7177 | Discontinued |
0.7202 | Intermediate Similarity | NPD7871 | Phase 2 |
0.7202 | Intermediate Similarity | NPD7870 | Phase 2 |
0.7188 | Intermediate Similarity | NPD6823 | Phase 2 |
0.7179 | Intermediate Similarity | NPD1283 | Approved |
0.7178 | Intermediate Similarity | NPD1510 | Phase 2 |
0.7178 | Intermediate Similarity | NPD2799 | Discontinued |
0.7173 | Intermediate Similarity | NPD6782 | Approved |
0.7173 | Intermediate Similarity | NPD6779 | Approved |
0.7173 | Intermediate Similarity | NPD6777 | Approved |
0.7173 | Intermediate Similarity | NPD6778 | Approved |
0.7173 | Intermediate Similarity | NPD6781 | Approved |
0.7173 | Intermediate Similarity | NPD6776 | Approved |
0.7173 | Intermediate Similarity | NPD6780 | Approved |
0.7169 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7168 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.716 | Intermediate Similarity | NPD1607 | Approved |
0.7157 | Intermediate Similarity | NPD7782 | Clinical (unspecified phase) |
0.7157 | Intermediate Similarity | NPD7783 | Phase 2 |
0.715 | Intermediate Similarity | NPD7697 | Approved |
0.715 | Intermediate Similarity | NPD7696 | Phase 3 |
0.715 | Intermediate Similarity | NPD7435 | Discontinued |
0.715 | Intermediate Similarity | NPD7698 | Approved |
0.7143 | Intermediate Similarity | NPD7240 | Approved |
0.7143 | Intermediate Similarity | NPD3620 | Phase 2 |
0.7143 | Intermediate Similarity | NPD3749 | Approved |
0.7143 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD3619 | Clinical (unspecified phase) |
0.7135 | Intermediate Similarity | NPD8434 | Phase 2 |
0.7119 | Intermediate Similarity | NPD1247 | Approved |
0.7119 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7115 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.7092 | Intermediate Similarity | NPD7701 | Phase 2 |
0.7091 | Intermediate Similarity | NPD2343 | Clinical (unspecified phase) |
0.7079 | Intermediate Similarity | NPD5711 | Approved |
0.7079 | Intermediate Similarity | NPD5710 | Approved |
0.7071 | Intermediate Similarity | NPD7801 | Approved |
0.7068 | Intermediate Similarity | NPD7699 | Phase 2 |
0.7068 | Intermediate Similarity | NPD7700 | Phase 2 |
0.7063 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7059 | Intermediate Similarity | NPD6273 | Approved |
0.7055 | Intermediate Similarity | NPD6651 | Approved |
0.7039 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7039 | Intermediate Similarity | NPD3926 | Phase 2 |
0.7037 | Intermediate Similarity | NPD943 | Approved |
0.7037 | Intermediate Similarity | NPD1240 | Approved |
0.7037 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7037 | Intermediate Similarity | NPD2979 | Phase 3 |
0.703 | Intermediate Similarity | NPD1551 | Phase 2 |
0.703 | Intermediate Similarity | NPD2438 | Suspended |
0.7029 | Intermediate Similarity | NPD5402 | Approved |
0.702 | Intermediate Similarity | NPD7874 | Approved |
0.702 | Intermediate Similarity | NPD7875 | Clinical (unspecified phase) |
0.7019 | Intermediate Similarity | NPD3764 | Approved |
0.7019 | Intermediate Similarity | NPD2313 | Discontinued |
0.7018 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7013 | Intermediate Similarity | NPD1651 | Approved |
0.7011 | Intermediate Similarity | NPD6801 | Discontinued |
0.7006 | Intermediate Similarity | NPD919 | Approved |
0.7 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7 | Intermediate Similarity | NPD6534 | Approved |
0.7 | Intermediate Similarity | NPD6535 | Approved |
0.6995 | Remote Similarity | NPD7501 | Clinical (unspecified phase) |
0.6994 | Remote Similarity | NPD447 | Suspended |
0.6994 | Remote Similarity | NPD6599 | Discontinued |
0.6988 | Remote Similarity | NPD1550 | Clinical (unspecified phase) |
0.6988 | Remote Similarity | NPD2344 | Approved |
0.6988 | Remote Similarity | NPD1552 | Clinical (unspecified phase) |
0.6987 | Remote Similarity | NPD1281 | Approved |
0.6981 | Remote Similarity | NPD2798 | Approved |
0.6964 | Remote Similarity | NPD3750 | Approved |
0.6946 | Remote Similarity | NPD1549 | Phase 2 |
0.6939 | Remote Similarity | NPD8320 | Phase 1 |
0.6939 | Remote Similarity | NPD8319 | Approved |
0.6935 | Remote Similarity | NPD7090 | Clinical (unspecified phase) |
0.6923 | Remote Similarity | NPD6190 | Approved |
0.6914 | Remote Similarity | NPD4907 | Clinical (unspecified phase) |
0.6905 | Remote Similarity | NPD2800 | Approved |
0.689 | Remote Similarity | NPD230 | Phase 1 |
0.6889 | Remote Similarity | NPD7229 | Phase 3 |
0.6889 | Remote Similarity | NPD3787 | Discontinued |
0.6888 | Remote Similarity | NPD7680 | Approved |
0.6882 | Remote Similarity | NPD3300 | Phase 2 |
0.6867 | Remote Similarity | NPD651 | Clinical (unspecified phase) |
0.6864 | Remote Similarity | NPD6398 | Clinical (unspecified phase) |
0.6859 | Remote Similarity | NPD4626 | Approved |
0.6859 | Remote Similarity | NPD6212 | Phase 3 |
0.6859 | Remote Similarity | NPD6214 | Clinical (unspecified phase) |
0.6859 | Remote Similarity | NPD6213 | Phase 3 |
0.6856 | Remote Similarity | NPD7237 | Clinical (unspecified phase) |
0.6842 | Remote Similarity | NPD6799 | Approved |
0.6832 | Remote Similarity | NPD1530 | Clinical (unspecified phase) |
0.6831 | Remote Similarity | NPD3751 | Discontinued |
0.6829 | Remote Similarity | NPD1612 | Clinical (unspecified phase) |
0.6829 | Remote Similarity | NPD1613 | Approved |
0.6826 | Remote Similarity | NPD6100 | Approved |
0.6826 | Remote Similarity | NPD2796 | Approved |
0.6826 | Remote Similarity | NPD6099 | Approved |
0.6824 | Remote Similarity | NPD2309 | Approved |
0.6821 | Remote Similarity | NPD5403 | Approved |
0.681 | Remote Similarity | NPD6798 | Discontinued |
0.6805 | Remote Similarity | NPD5698 | Clinical (unspecified phase) |
0.68 | Remote Similarity | NPD7028 | Phase 2 |
0.6792 | Remote Similarity | NPD3600 | Clinical (unspecified phase) |
0.679 | Remote Similarity | NPD1529 | Clinical (unspecified phase) |
0.679 | Remote Similarity | NPD4908 | Phase 1 |
0.6788 | Remote Similarity | NPD6355 | Discontinued |
0.6786 | Remote Similarity | NPD7266 | Discontinued |
0.678 | Remote Similarity | NPD5760 | Phase 2 |
0.678 | Remote Similarity | NPD5761 | Phase 2 |
0.6774 | Remote Similarity | NPD7038 | Approved |
0.6774 | Remote Similarity | NPD7039 | Approved |
0.6763 | Remote Similarity | NPD8155 | Clinical (unspecified phase) |
0.6763 | Remote Similarity | NPD7907 | Approved |
0.6761 | Remote Similarity | NPD7922 | Phase 1 |
0.6761 | Remote Similarity | NPD6386 | Approved |
0.6761 | Remote Similarity | NPD6385 | Approved |
0.6748 | Remote Similarity | NPD4625 | Phase 3 |
0.6748 | Remote Similarity | NPD7008 | Discontinued |
0.6742 | Remote Similarity | NPD5616 | Clinical (unspecified phase) |
0.6739 | Remote Similarity | NPD7893 | Clinical (unspecified phase) |
0.6732 | Remote Similarity | NPD5283 | Phase 1 |
0.6726 | Remote Similarity | NPD2531 | Phase 2 |
PubChem CID   | 375713 |
ChEMBL   | CHEMBL112743 |
ZINC   |
Molecular Weight:   | 546.23 |
ALogP:   | 0.1002 |
MLogP:   | 4.1 |
XLogP:   | 5.69 |
# Rotatable Bonds:   | 19 |
Polar Surface Area:   | 133.52 |
# H-Bond Aceptor:   | 2 |
# H-Bond Donor:   | 4 |
# Rings:   | 4 |
# Heavy Atoms:   | 40 |